Advanced search
Publication Cover
Autoimmunity Volume 38, 2005 - Issue 7
Submit an article Journal homepage
558
Views
104
CrossRef citations to date
0
Altmetric
Original

RETRACTED: Drug-induced lupus erythematosus

Piercarlo Sarzi-Puttini Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Fabiola Atzeni Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Piercarlo Sarzi-Puttini Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Fabiola Atzeni Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Franco Capsoni Ospedale Maggiore Policlinico, IRCCS, University of Milan, Department of Internal Medicine, Milan, Italy
,
Piercarlo Sarzi-Puttini Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Fabiola Atzeni Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Franco Capsoni Ospedale Maggiore Policlinico, IRCCS, University of Milan, Department of Internal Medicine, Milan, Italy
,
Ennio Lubrano Rheumatology and Rehabilitation Research Unit, Maugeri Foudation IRCCS, Research Institute for Rehabilitative Medicine, Telese Terme, Italy
,
Piercarlo Sarzi-Puttini Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Fabiola Atzeni Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Franco Capsoni Ospedale Maggiore Policlinico, IRCCS, University of Milan, Department of Internal Medicine, Milan, Italy
,
Ennio Lubrano Rheumatology and Rehabilitation Research Unit, Maugeri Foudation IRCCS, Research Institute for Rehabilitative Medicine, Telese Terme, Italy
,
Andrea Doria Chair of Rheumatology, University of Padova, Padova, Italy
,
Piercarlo Sarzi-Puttini Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Fabiola Atzeni Rheumatology Unit, L Sacco University Hospital, Department of Rheumatology, via GB Grassi 74, Milan, 20157, Italy
,
Franco Capsoni Ospedale Maggiore Policlinico, IRCCS, University of Milan, Department of Internal Medicine, Milan, Italy
,
Ennio Lubrano Rheumatology and Rehabilitation Research Unit, Maugeri Foudation IRCCS, Research Institute for Rehabilitative Medicine, Telese Terme, Italy
&
Andrea Doria Chair of Rheumatology, University of Padova, Padova, Italy
 show all
Pages 507-518 | Published online: 07 Jul 2009

Citations (104)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Maliha Ahmed, Tanzy Love, Catherine Moore, Thu H. Le, Jerome Jean-Gilles, Bruce Goldman & Hae Yoon Grace Choung. (2022) The spectrum of renal diseases with lupus-like features: a single-center study. Renal Failure 44:1, pages 581-593.
Read now
Anna Campanati, Matteo Paolinelli, Frederico Diotallevi, Emanuela Martina, Elisa Molinelli & Annamaria Offidani. (2019) Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 913-925.
Read now
Sandra M. Quezada, Leon P. McLean & Raymond K. Cross. (2018) Adverse events in IBD therapy: the 2018 update. Expert Review of Gastroenterology & Hepatology 12:12, pages 1183-1191.
Read now
Liudmila Korkina. (2016) Metabolic and redox barriers in the skin exposed to drugs and xenobiotics. Expert Opinion on Drug Metabolism & Toxicology 12:4, pages 377-388.
Read now
Michael I. Luster. (2014) A historical perspective of immunotoxicology. Journal of Immunotoxicology 11:3, pages 197-202.
Read now
Leon P McLean & Raymond K Cross. (2014) Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Review of Gastroenterology & Hepatology 8:3, pages 223-240.
Read now
Olivera Stojadinovic, Elizabeth Lebrun, Irena Pastar, Robert Kirsner, Stephen C Davis & Marjana Tomic-Canic. (2010) Statins as potential therapeutic agents for healing disorders. Expert Review of Dermatology 5:6, pages 689-698.
Read now
Piercarlo Sarzi-Puttini & Andrea Doria. (2008) Organ specific-autoantibodies: Their role as markers and predictors of disease. Autoimmunity 41:1, pages 1-10.
Read now
Sabrina Boscolo & Enrico Tongiorgi. (2007) Quantification of antineural antibodies in autoimmune neurological disorders. Expert Review of Clinical Immunology 3:6, pages 949-973.
Read now
Jeff C. Huffman & Theodore A. Stern. (2007) Neuropsychiatric consequences of cardiovascular medications. Dialogues in Clinical Neuroscience 9:1, pages 29-45.
Read now
Andreas Jönsen, Anders A. Bengtsson, Ola Nived, Lennart Truedsson & Gunnar Sturfelt. (2007) Gene–environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 40:8, pages 613-617.
Read now
Piercarlo Sarzi-Puttini, Fabiola Atzeni, Luca Iaccarino & Andrea Doria. (2005) Environment and systemic lupus erythematosus: An overview. Autoimmunity 38:7, pages 465-472.
Read now

Articles from other publishers (92)

Neeraj Sharma, Kunal Kumar, Sarvinder Singh, Puneet Saxena, Nalin Singh & Akhil Kollammarukudy Ravi. (2023) Rare adverse effects of anti tuberculous therapy − a case series. The Journal of Association of Chest Physicians 11:1, pages 43.
Crossref
Ivan Alajbeg, Stephen J. Challacombe, Palle Holmstrup & Mats Jontell. 2021. Burket's Oral Medicine. Burket's Oral Medicine 85 138 .
Ashley Fonseca, Julee Sunny & Lina M. Felipez. (2021) Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease. Case Reports in Pediatrics 2021, pages 1-3.
Crossref
Saurabh Nimesh, Md. Iftekhar Ahmad, Shikhka Dhama, Pradeep Kumar, Muhammad Akram & Neda Esmaeili Nejad Hasaroeih. (2021) Systemic Lupus Erythematosus Disease: An Overview of the Clinical Approach to Pathogenesis, Diagnosis, and Treatment. Borneo Journal of Pharmacy 4:2, pages 91-98.
Crossref
Jérémie Sellam, Jacques Morel, Anne Tournadre, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Dieudé, Philippe Goupille, Denis Jullien, Nicolas Kluger, Estibaliz Lazaro, Benoit Le Goff, Victor de Lédinghen, Thierry Lequerré, Gaëtane Nocturne, Raphaèle Seror, Marie-Elise Truchetet, Frank Verhoeven, Thao Pham & Christophe Richez. (2021) Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 88:2, pages 105174.
Crossref
Anna Strasma, Howard Coke, Omar Mamlouk, Amanda Tchakarov & Sreedhar Mandayam. (2021) Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor. Kidney Medicine 3:2, pages 294-298.
Crossref
Xuejiao Wang, Yingzhuo Li, Yuchen Wang, Qianhui Feng, Pingting Yang & Ling Qin. (2019) Intracerebroventricular administration of lupus serum induces microglia activation and leukocyte adhesion in the cerebromicrovasculature of mice. Journal of Neuroimmunology 334, pages 576994.
Crossref
Vasileios S. Skouras & I. Kalomenidis. (2019) Pleurotoxic Drugs—an Update: Someone Else to Blame?. Current Pulmonology Reports 8:2, pages 50-59.
Crossref
C. Iking-Konert, W.-J. Mayet, S. Kuchen, J. Jenewein, S. Büchi, H. Zeidler & B. Michel. 2019. Differenzialdiagnose rheumatischer Erkrankungen. Differenzialdiagnose rheumatischer Erkrankungen 363 507 .
N. G. KlyukvinaV. M. GunchikovaA. M. Novikova. (2018) Drug-induced lupus. Modern Rheumatology Journal 12:4, pages 32-41.
Crossref
Ye He & Amr H. Sawalha. (2018) Drug-induced lupus erythematosus: an update on drugs and mechanisms. Current Opinion in Rheumatology 30:5, pages 490-497.
Crossref
P. S. S. Ranugha & JayadevB Betkerur. (2018) Antihypertensives in dermatology Part II - Cutaneous adverse reactions to antihypertensives. Indian Journal of Dermatology, Venereology and Leprology 84:2, pages 137.
Crossref
Yu. V. Muravyev, V. V. Lebedeva & S. Yu. Alamankina. (2017) INFLIXIMAB-INDUCED LUPUS-LIKE SYNDROME IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS (A CASE REPORT): AN ACCIDENT OR REGULARITY?. Rheumatology Science and Practice 55:4, pages 446-448.
Crossref
Ana María Molina‐Ruiz, Begoña Lasanta, Ana Barcia, Elisa Pérez‐Vega & Luis Requena. (2015) Drug‐induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine. Australasian Journal of Dermatology 58:1.
Crossref
Marcella Prete, Francesco Indiveri & Federico Perosa. (2016) Vasculitides: Proposal for an integrated nomenclature. Autoimmunity Reviews 15:2, pages 167-173.
Crossref
S G Ong & C H Choy. (2015) Autoimmune thyroid disease in a cohort of Malaysian SLE patients: frequency, clinical and immunological associations. Lupus 25:1, pages 67-74.
Crossref
Amy S. Paller & Anthony J. Mancini. 2016. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 509 539.e8 .
Mary Anne Dooley. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 473 479 .
Ersin Ozaslan, Eray Eroglu, Kevser Gok, Soner Senel, Suleyman Baldane, Lutfi Akyol & Metin Ozkan. (2015) Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia. Romanian Journal Of Internal Medicine 53:3, pages 282-285.
Crossref
Jonathan J. Hogan, Glen S. Markowitz & Jai Radhakrishnan. (2015) Drug-Induced Glomerular Disease. Clinical Journal of the American Society of Nephrology 10:7, pages 1300-1310.
Crossref
Maria Victória Quaresma, Fred Bernardes Filho, Fernanda Brandão de Oliveira, Mercedes Prates Pockstaller, Maria Fernanda Reis Gavazzoni Dias & David Rubem Azulay. (2015) Anti-TNF-α and hydralazine drug-induced lupus. Anais Brasileiros de Dermatologia 90:3 suppl 1, pages 125-129.
Crossref
Michael I. Luster. 2014. Molecular Immunotoxicology. Molecular Immunotoxicology 1 10 .
S Araújo-Fernández, M Ahijón-Lana & DA Isenberg. (2014) Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced. Lupus 23:6, pages 545-553.
Crossref
Özgür Akgül, Gamze Kılıç, Erkan Kılıç, İsa Cüce & Salih Özgöçmen. (2012) A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept. Rheumatology International 34:3, pages 443-444.
Crossref
Yao-Ko Wen & Kai-I Wen. (2012) An unusual cause of non-infectious peritonitis in a peritoneal dialysis patient. International Urology and Nephrology 46:1, pages 265-268.
Crossref
G. W. Moran, A. W. K. Lim, J. L. Bailey, M.-F. Dubeau, Y. Leung, S. M. Devlin, K. Novak, G. G. Kaplan, M. Iacucci, C. Seow, L. Martin, R. Panaccione & S. Ghosh. (2013) Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 38:9, pages 1002-1024.
Crossref
Natalia P. Machado, Edgard Torres dos Reis Neto, Maria Roberta M.P. Soares, Daniele S. Freitas, Adriana Porro, Rozana M. Ciconelli & Marcelo M. Pinheiro. (2013) The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis. Clinics 68:9, pages 1189-1196.
Crossref
Edoardo Zattra, Roxana Stan, Irene Russo, Alessandro Lo Nigro, Andrea Peserico & Mauro Alaibac. (2013) TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?. Immunotherapy 5:8, pages 791-794.
Crossref
Christine M. Lin, Julia J. Rhiannon & Edward D. Chan. (2013) Drug-induced pleural disease. Adverse Drug Reaction Bulletin 281:1, pages 1083-1086.
Crossref
Henry Anyimadu, Naseem Saadia & Sharon Mannheimer. (2013) Drug-Induced Lupus Associated with Rifabutin. Journal of the International Association of Providers of AIDS Care (JIAPAC) 12:3, pages 166-168.
Crossref
Philip Hasleton, Francoise Galateau-Salle, Juliet King, Giulio Rossi, Sylvie Lantuejoul, Rebecca Preston, Durgesh N. Rana & Godfrey Wilson. 2014. Spencer's Pathology of the Lung. Spencer's Pathology of the Lung 1408 1564 .
Adrian Reuben. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease 569 591 .
J. Ben Amar, B. Dhahri, H. Smadhi, S. Azzabi, M.A. Baccar, H. Aouina, L. El Gharbi & H. Bouacha. (2012) Lupus érythémateux systémique induit par l’isoniazide. Revue Française d'Allergologie 52:6, pages 462-464.
Crossref
Jennifer C. Samp, Glen T. Schumock & A. Simon Pickard. (2012) Retracted Publications in the Drug Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:7, pages 586-595.
Crossref
Yu-Chao Lin, Shinn-Jye Liang, Yi-Heng Liu, Wu-Huei Hsu, Chuen-Ming Shih, Fung-Chang Sung & Wei Chen. (2011) Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatology International 32:6, pages 1669-1673.
Crossref
Masahiro Okabe, Nobuo Tsuboi, Takashi Yokoo, Yoichi Miyazaki, Yasunori Utsunomiya & Tatsuo Hosoya. (2011) A case of idiopathic membranoproliferative glomerulonephritis with a transient glomerular deposition of nephritis-associated plasmin receptor antigen. Clinical and Experimental Nephrology 16:2, pages 337-341.
Crossref
G Zandman-GoddardM SolomonZ RosmanE PeevaY Shoenfeld. (2011) Environment and lupus-related diseases. Lupus 21:3, pages 241-250.
Crossref
Eduardo Puertas-Abreu, Elaudi Polanco, Miriam Azocar, Luis Mundarain, Concepción Nuñez-Sotelo, Rafael Montaño, Freddy Vivas, Zair Noguera, Francisco Marín, Omar Bellorin, José Rivas, Eduardo Toro, Eugenia Benzaquen, Mayra Rauseo & Luis Gutiérrez González. (2012) Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α. International Archives of Medicine 5:1, pages 7.
Crossref
Anette Holck Draborg, Karen Duus & Gunnar Houen. (2012) Epstein-Barr Virus and Systemic Lupus Erythematosus. Clinical and Developmental Immunology 2012, pages 1-10.
Crossref
Moran Landau Rabbi, Ilan Ben-Zvi, Nancy Agmon-Levin & Yehuda Shoenfeld. 2012. Immunotoxicity, Immune Dysfunction, and Chronic Disease. Immunotoxicity, Immune Dysfunction, and Chronic Disease 193 213 .
Pia Vihinen, Outi Paija, Atte Kivisaari, Leena Koulu & Heikki Aho. (2011) Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. Journal of Medical Case Reports 5:1.
Crossref
Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Philippe Gaudin, Vincent Goëb, Laure Gossec, Philippe Goupille, Séverine Guillaume-Czitrom, Eric Hachulla, Isabelle Huet, Denis Jullien, Odile Launay, Marc Lemann, Jean-Francis Maillefert, Jean-Pierre Marolleau, Valérie Martinez, Charles Masson, Jacques Morel, Luc Mouthon, Stanislas Pol, Xavier Puéchal, Pascal Richette, Alain Saraux, Thierry Schaeverbeke, Martin Soubrier, Anne Sudre, Tu-Anh Tran, Manuelle Viguier, Olivier Vittecoq, Daniel Wendling, Xavier Mariette & Jean Sibilia. (2011) TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine 78, pages 15-185.
Crossref
Idan Roifman, Paul L. Beck, Todd J. Anderson, Mark J. Eisenberg & Jacques Genest. (2011) Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review. Canadian Journal of Cardiology 27:2, pages 174-182.
Crossref
Amy S. Paller & Anthony J. Mancini. 2011. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 497 527 .
Mollie Dahlgren, Arezou Khosroshahi & John H. Stone. (2011) A 22-year-old woman with severe headaches, vomiting, and tonic-clonic seizures. Arthritis Care & Research 63:1, pages 165-171.
Crossref
Uriel Katz & Gisele Zandman-Goddard. (2010) Drug-induced lupus: An update. Autoimmunity Reviews 10:1, pages 46-50.
Crossref
Benno Schnyder. (2010) Approach to the Patient with Drug Allergy. Medical Clinics of North America 94:4, pages 665-679.
Crossref
Hobart W. Walling & Richard D. Sontheimer. (2009) Cutaneous Lupus Erythematosus. American Journal of Clinical Dermatology 10:6, pages 365-381.
Crossref
J.L. Rakotoson, D. Randriamanana, J.R. Rakotomizao, R. Andrianasolo, R. Rakotoarivelo & A.C.F. Andrianarisoa. (2009) Lupus érythémateux systémique grave induit par l’isoniazide. Revue de Pneumologie Clinique 65:6, pages 361-364.
Crossref
David A. Wetter & Mark D.P. Davis. (2009) Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic. Mayo Clinic Proceedings 84:11, pages 979-984.
Crossref
David A. Wetter & Mark D.P. Davis. (2009) Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic. Mayo Clinic Proceedings 84:11, pages 979-984.
Crossref
AV Marzano, P Vezzoli & C Crosti. (2009) Drug-induced lupus: an update on its dermatologic aspects. Lupus 18:11, pages 935-940.
Crossref
Garrett C Zella, Michael E Weinblatt & Harland S Winter. (2009) Drug-induced Lupus Associated With Infliximab and Adalimumab in an Adolescent With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 49:3, pages 355-358.
Crossref
Aikaterini-Evaggelia Moustou, Athina Matekovits, Clio Dessinioti, Christina Antoniou, Petros P. Sfikakis & Alexander J. Stratigos. (2009) Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review. Journal of the American Academy of Dermatology 61:3, pages 486-504.
Crossref
E. Vidal, K. Ly, A.-L. Fauchais & J. Monteil. (2009) Fièvres prolongées d’origine inconnue. Médecine Nucléaire 33:8, pages 522-532.
Crossref
Benno Schnyder. (2009) Approach to the Patient with Drug Allergy. Immunology and Allergy Clinics of North America 29:3, pages 405-418.
Crossref
E. L. Williams, S. Gadola & C. J. Edwards. (2009) Anti-TNF-induced lupus. Rheumatology 48:7, pages 716-720.
Crossref
K Anam, M Amare, S Naik, KA Szabo & TA Davis. (2009) Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus 18:4, pages 318-331.
Crossref
Lois J. ArendTibor Nadasdy. (2009) Emerging Therapy-Related Kidney Disease. Archives of Pathology & Laboratory Medicine 133:2, pages 268-278.
Crossref
Jack Uetrecht. (2008) Immune-Mediated Adverse Drug Reactions. Chemical Research in Toxicology 22:1, pages 24-34.
Crossref
B Bonaci-Nikolic, I Jeremic, S Andrejevic, M Sefik-Bukilica, N Stojsavljevic & J Drulovic. (2009) Anti–double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis. Lupus 18:1, pages 78-80.
Crossref
Benno Schnyder & Werner J. Pichler. 2009. Allergy Frontiers: Diagnosis and Health Economics. Allergy Frontiers: Diagnosis and Health Economics 403 422 .
Adam Mor, Michael H. Pillinger, Robert L. Wortmann & Hal J. Mitnick. (2008) Drug-Induced Arthritic and Connective Tissue Disorders. Seminars in Arthritis and Rheumatism 38:3, pages 249-264.
Crossref
Sarah Bradshaw, W. Jim Zheng, Lam C. Tsoi, Gary Gilkeson & Xian K. Zhang. (2008) A role for Fli-1 in B cell proliferation: Implications for SLE pathogenesis. Clinical Immunology 129:1, pages 19-30.
Crossref
Danuta J. Herzyk. 2008. Immunotoxicology Strategies for Pharmaceutical Safety Assessment. Immunotoxicology Strategies for Pharmaceutical Safety Assessment 179 188 .
Z Birsin zakar, Fato Yalnkaya, alar dek & Mesiha Ekim. (2008) Oxcarbazepine and valproic acid-induced lupus in a 7-year-old boy. Acta Pdiatrica 97:8, pages 1000-1001.
Crossref
Michelle F. Costa, Nuha R. Said & Bernard Zimmermann. (2008) Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents. Seminars in Arthritis and Rheumatism 37:6, pages 381-387.
Crossref
MJ Zhou. (2008) Pay close attention to drug-induced lupus. Journal of Chinese Integrative Medicine 6:5, pages 458-462.
Crossref
AV Marzano, S Ramoni, N Del Papa, M Barbareschi & E Alessi. (2008) Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. Lupus 17:4, pages 329-331.
Crossref
A DoriaC Briani. (2008) Lupus: improving long-term prognosis. Lupus 17:3, pages 166-170.
Crossref
M. Trancart, A. Cavailhes, B. Balme & F. Skowron. (2007) Anastrozole-induced subacute cutaneous lupus erythematosus. British Journal of Dermatology 158:3, pages 628-629.
Crossref
Lucio Lo Russo, Stefano Fedele, Rosario Guiglia, Domenico Ciavarella, Lorenzo Lo Muzio, Pio Gallo, Chiara Di Liberto & Giuseppina Campisi. (2008) Diagnostic Pathways and Clinical Significance of Desquamative Gingivitis. Journal of Periodontology 79:1, pages 4-24.
Crossref
Andrea Doria, Silvia Arienti, Mariaelisa Rampudda, Mariagrazia Canova, Michele Tonon & Piercalo Sarzi-Puttini. (2008) Preventive strategies in systemic lupus erythematosus. Autoimmunity Reviews 7:3, pages 192-197.
Crossref
David Cella & Lesley J. Fallowfield. (2007) Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Research and Treatment 107:2, pages 167-180.
Crossref
F. Hiepe & T. Dörner. 2008. Interdisziplinäre klinische Rheumatologie. Interdisziplinäre klinische Rheumatologie 761 790 .
Joris J. Roelofs, Daniel Abramowicz & Sandrine Florquin. 2008. Clinical Nephrotoxins. Clinical Nephrotoxins 683 698 .
F. AHMED, P. R. KELSEY & N. SHARIFF. (2007) Lupus syndrome with neutropenia following minocycline therapy ? a case report. International Journal of Laboratory Hematology 0:0, pages 070908013905001-???.
Crossref
R Suchak, K. Benson & V. Swale. (2007) Statin-induced Ro/SSa-positive subacute cutaneous lupus erythematosus. Clinical and Experimental Dermatology 32:5, pages 589-591.
Crossref
Harold J. Burstein. (2007) Aromatase inhibitor-associated arthralgia syndrome. The Breast 16:3, pages 223-234.
Crossref
László Czirják, Csaba György Kiss & Emese Kiss. (2007) Does the number of patients with autoimmune disorders and the frequency of autoimmune diseases increase?. Orvosi Hetilap 148:Supplement-1, pages 17-20.
Crossref
Mark Gourley & Frederick W Miller. (2007) Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease. Nature Clinical Practice Rheumatology 3:3, pages 172-180.
Crossref
Rita Geddes. (2007) Minocycline-Induced Lupus in Adolescents: Clinical Implications for Physical Therapists. Journal of Orthopaedic & Sports Physical Therapy 37:2, pages 65-71.
Crossref
Deana Lazaro. (2007) Elderly-Onset Systemic Lupus Erythematosus. Drugs & Aging 24:9, pages 701-715.
Crossref
Bodo Brueckner, Dirk Kuck & Frank Lyko. (2007) DNA Methyltransferase Inhibitors for Cancer Therapy. The Cancer Journal 13:1, pages 17-22.
Crossref
B. Bannwarth. (2007) Manifestaciones iatrogénicas de los tratamientos reumatológicos y manifestaciones reumatológicas asociadas a medicamentos. EMC - Aparato Locomotor 40:2, pages 1-7.
Crossref
B. Bannwarth. (2007) Manifestations iatrogènes des traitements rhumatologiques et manifestations rhumatologiques des thérapeutiques. EMC - Appareil locomoteur 2:1, pages 1-7.
Crossref
V. Wahn. (2006) Medikamentös induzierter Lupus erythematodesDrug-induced Lupus erythematodes. Monatsschrift Kinderheilkunde 154:12, pages 1207-1209.
Crossref
S Vasoo. (2016) Drug-induced lupus: an update. Lupus 15:11, pages 757-761.
Crossref
Salvatore De Vita & Luca Quartuccio. (2006) Treatment of rheumatoid arthritis with rituximab: An update and possible indications. Autoimmunity Reviews 5:7, pages 443-448.
Crossref
Catherine A. Schnabel, S. Edwin Fineberg & Dennis D. Kim. (2006) Immunogenicity of xenopeptide hormone therapies. Peptides 27:7, pages 1902-1910.
Crossref
Claudia Arce, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Myrna Candelaria & Alfonso Dueñnas-Gonzalez. (2006) Hydralazine target: From blood vessels to the epigenome. Journal of Translational Medicine 4:1.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:6, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.